With healthcare thrust into digitisation by the COVID-19 pandemic, digital health is now being heralded as the next trillion-dollar global industry.
CEOs from leading U.S. companies discuss business impacts of the pandemic and the need to prioritize public health.
Makers of ventilators and test kits have fared well during COVID-19, while others have seen sales shrivel due to cancelled medical procedures.
India’s pharmaceutical industry could emerge from the pandemic stronger, as production of potential COVID-19 drugs goes into overdrive.
A new focus on the human element is changing the profile of the successful healthcare leader.
Perspectives from Boyden's Technology Practice Experts
Perspectives from our Healthcare & Life Sciences Practice
Google is making a push into digital health, including the use of artificial intelligence to analyse patient data, stoking concerns about privacy.
CEO Vas Narasimhan seeks to transform the Swiss multinational into a cutting-edge pharmaceuticals firm that embraces digital healthcare technology.